SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-002244
Filing Date
2019-03-18
Accepted
2019-03-18 16:42:50
Documents
72
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ampe-20181231x10k.htm 10-K 2754549
2 EX-23.1 ampe-20181231ex2315467eb.htm EX-23.1 5691
3 EX-23.2 ampe-20181231ex23246a2f1.htm EX-23.2 5686
4 EX-31.1 ampe-20181231ex311c3600e.htm EX-31.1 10873
5 EX-31.2 ampe-20181231ex312de11cc.htm EX-31.2 10140
6 EX-32.1 ampe-20181231ex32164f54a.htm EX-32.1 10284
7 GRAPHIC ampe20181231x10k001.jpg GRAPHIC 4975
  Complete submission text file 0001558370-19-002244.txt   8297575

Data Files

Seq Description Document Type Size
8 EX-101.INS ampe-20181231.xml EX-101.INS 1615569
9 EX-101.SCH ampe-20181231.xsd EX-101.SCH 53175
10 EX-101.CAL ampe-20181231_cal.xml EX-101.CAL 42058
11 EX-101.DEF ampe-20181231_def.xml EX-101.DEF 228971
12 EX-101.LAB ampe-20181231_lab.xml EX-101.LAB 396660
13 EX-101.PRE ampe-20181231_pre.xml EX-101.PRE 393269
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35182 | Film No.: 19688789
SIC: 2834 Pharmaceutical Preparations